Target intelligence / Profile preview

Bacterial type I signal peptidase (SPase I) (SPase I)

Target
SPase I
Molecular classification
Enzyme, Serine protease, Hydrolase
01

Overview

Bacterial type I signal peptidase (SPase I) is an essential membrane-bound serine protease found in all bacteria, where it plays a pivotal role in the protein secretion pathway (UniProt). Its primary function is to cleave the amino-terminal signal peptide from pre-proteins as they emerge from the Sec or Tat translocation machinery, a step necessary for the maturation and proper localization of extracellular and periplasmic proteins (PubMed: 12446561). Because SPase I is indispensable for bacterial growth and possesses a unique catalytic Ser-Lys dyad that differs significantly from the catalytic mechanisms of eukaryotic signal peptidases, it is considered a high-priority target for novel antibiotic discovery (Nature: 10.1038/s41586-018-0483-6). Inhibitors such as the natural product arylomycins and their synthetic derivatives, like G-7485, have demonstrated potent antibacterial activity by blocking this cleavage event, leading to the accumulation of toxic unprocessed proteins in the bacterial membrane (Science: 10.1126/science.aar5592). This mechanism of action is effective against a wide range of pathogens, including multi-drug resistant strains, making SPase I a promising focus for future therapeutic development.

Other names
Signal peptidase ILeader peptidase ILepBType I signal peptidaseType I SPase
02

Mechanism of action

Inhibitors bind to the catalytic site of SPase I, blocking the Ser-Lys dyad from cleaving signal peptides. This prevents the maturation of secreted proteins, causing them to remain tethered to the cytoplasmic membrane, which triggers bacterial cell death (PubMed: 12446561).

03

Biological functions

Protein secretionSignal peptide cleavagePost-translational modificationProtein maturation
04

Disease associations

InfectionBacterial infection
05

Safety considerations

Development of bacterial resistance via lepB mutationsPotential for narrow spectrum of activity in some chemical classesRequirement for high selectivity to avoid human signal peptidase inhibition (PubMed: 15102847)
06

Interacting drugs

Arylomycin A

5 more in the full profile.

07

Biomarkers

Bacterial load (CFU/mL)Accumulation of pre-proteinsProcalcitoninC-reactive protein

Beyond the preview

Go deeper on Bacterial type I signal peptidase (SPase I) (SPase I).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial type I signal peptidase (SPase I) (SPase I).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call